Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | PIK3CA |
Variant | H450_P458del |
Impact List | deletion |
Protein Effect | gain of function |
Gene Variant Descriptions | PIK3CA H450_P458del results in the deletion of nine amino acids in the C2 PI3K-type domain of the Pik3ca protein from amino acids 450 to 458 (UniProt.org). H450_P458del confers a gain of function to the Pik3ca protein as demonstrated by transformation in culture and activation of the PI3K/Akt/Mtor pathway via increased phosphorylation of Akt, Erk, P70S6K, and P90RSK (PMID: 29284706). |
Associated Drug Resistance | |
Category Variants Paths |
PIK3CA mutant PIK3CA act mut PIK3CA H450_P458del PIK3CA mutant PIK3CA exon8 PIK3CA H450_P458del |
Transcript | NM_006218.4 |
gDNA | chr3:g.179210282_179210308del27 |
cDNA | c.1348_1374del27 |
Protein | p.H450_P458delHGLEDLLNP |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_011512894.2 | chr3:g.179210282_179210308del27 | c.1348_1374del27 | p.H450_P458delHGLEDLLNP | RefSeq | GRCh38/hg38 |
XM_006713658.5 | chr3:g.179210282_179210308del27 | c.1348_1374del27 | p.H450_P458delHGLEDLLNP | RefSeq | GRCh38/hg38 |
NM_006218 | chr3:g.179210282_179210308del27 | c.1348_1374del27 | p.H450_P458delHGLEDLLNP | RefSeq | GRCh38/hg38 |
XM_006713658.4 | chr3:g.179210282_179210308del27 | c.1348_1374del27 | p.H450_P458delHGLEDLLNP | RefSeq | GRCh38/hg38 |
NM_006218.3 | chr3:g.179210282_179210308del27 | c.1348_1374del27 | p.H450_P458delHGLEDLLNP | RefSeq | GRCh38/hg38 |
XM_006713658 | chr3:g.179210282_179210308del27 | c.1348_1374del27 | p.H450_P458delHGLEDLLNP | RefSeq | GRCh38/hg38 |
XM_011512894 | chr3:g.179210282_179210308del27 | c.1348_1374del27 | p.H450_P458delHGLEDLLNP | RefSeq | GRCh38/hg38 |
NM_006218.4 | chr3:g.179210282_179210308del27 | c.1348_1374del27 | p.H450_P458delHGLEDLLNP | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
PIK3CA H450_P458del | breast cancer | sensitive | Alpelisib | Preclinical - Cell culture | Actionable | In a preclinical study, transformed breast epithelial cells expressing PIK3CA H450_P458del were sensitive to treatment with Alpelisib (BYL719) in culture, demonstrating growth inhibition and decreased invasiveness of acini (PMID: 29284706). | 29284706 |